It's a huge deal for your team and investors, but don't expect any applauds.

		hvass on Oct 12, 2011 \| parent \| context \| favorite \| on: Monsanto chooses Cloudant to power its genome anal... It's a huge deal for your team and investors, but don't expect any applauds.